Skip to main content

Table 3 Prevalence and odds ratio of coronary heart diseases across glycemic categories: Tehran Lipid and Glucose Study (phase IV: 2008–2011)

From: Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011

 

Case/Total

Crude prevalence % (95% CI)

Age-standardized prevalence a % (95% CI)

Crude

odds ratio

(95% CI)

Age and sex adjusted odds ratio (95% CI)

Full-adjusted odds ratio b

(95% CI)

NFG/NGT

247/4422

5.59 (4.91–6.26)

6.39 (5.59–7.19)

Reference

Reference

Reference

iIFG

105/1171

8.97 (7.33–10.60)

6.52 (5.23–7.82)

1.67 (1.31–2.11)

1.13 (0.88–1.45)

0.99 (0.76–1.27)

iIGT

45/404

11.14 (8.07–14.21)

7.00 (4.73–9.27)

2.12 (1.52–2.96)

1.17 (0.82–1.67)

0.95 (0.66–1.38)

IFG/IGT

64/465

13.76 (10.63–16.90)

8.04 (5.40–10.67)

2.70 (2.01–3.62)

1.38 (1.01–1.89)

1.07 (0.78–1.47)

NDM

98/529

18.53 (15.21–21.84)

8.74 (7.08–10.40)

3.84 (2.98–4.96)

1.83 (1.40–2.41)

1.40 (1.06–1.86)

KDM

191/727

26.27 (23.07–29.47)

14.26 (10.73–17.79)

6.02 (4.89–7.43)

2.83 (2.26–3.55)

1.91 (1.51–2.43)

Total

750/7718

9.72 (9.06–10.38)

7.71 (7.18–8.24)

_

_

_

  1. NFG Normal fasting glucose, NGT Normal glucose tolerance, iIFG Isolated impaired fasting glucose, iIGT Isolated impaired glucose tolerance, IFG/IGT Both impaired fasting glucose and impaired glucose tolerance, NDM Newly diagnosed diabetes mellitus, KDM Known diabetes mellitus, CI Confidence interval
  2. aAge-standardized prevalence is calculated based on Iranian population distribution data from the National Consensus Bureau for Tehran province (2010)
  3. bAdjusted for age, sex, BMI, hypercholesterolemia, low high-density lipoprotein cholesterol, hypertension, family history of premature cardiovascular disease, and smoking status